tirzepatide from eli lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can China Clears Eli Lilly's Weight

That means roughly 25% of employers are receiving something less than a guaranteed full pass-through on traditional drugs and the arrangement for that 25% is often governed by contracts that do not disclose the actual rebate amount received from manufacturers

This is why refrigeration is not just recommended

Shannon Wellness & Weight Loss , we know that navigating insurance coverage can be frustrating especially when policies change unexpectedly

Whether hyperglycaemia itself directly affects the pathogenesis of atherosclerosis and heart failure remains inconclusive

CEO Tamar Grossman says the recognition reflects how far the company has come despite limited resources